Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
23.26
-0.13 (-0.56%)
At close: Apr 16, 2026, 4:00 PM EDT
23.38
+0.12 (0.52%)
After-hours: Apr 16, 2026, 4:25 PM EDT
Immunome Employees
Immunome had 177 employees as of December 31, 2025. The number of employees increased by 59 or 50.00% compared to the previous year.
Employees
177
Change (1Y)
59
Growth (1Y)
50.00%
Revenue / Employee
$39,215
Profits / Employee
-$1,199,966
Market Cap
2.63B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 177 | 59 | 50.00% |
| Dec 31, 2024 | 118 | 63 | 114.55% |
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | 39 | 16 | 69.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Ultragenyx Pharmaceutical | 1,371 |
| Ascentage Pharma Group International | 767 |
| ADMA Biologics | 647 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
| Disc Medicine | 155 |
| Kodiak Sciences | 124 |
IMNM News
- 2 days ago - Immunome (IMNM) Price Forecast: Breakout Points to Higher Highs Ahead - FXEmpire
- 14 days ago - Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Immunome Reports Full Year 2025 Financial Results and Provides Business Update - Business Wire
- 7 weeks ago - Immunome to Present at Upcoming Investor Conferences - Business Wire
- 2 months ago - Immunome to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - Business Wire
- 3 months ago - Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 months ago - Immunome Announces Pricing of Public Offering of Common Stock - Business Wire
- 4 months ago - Immunome Announces Proposed Public Offering of Common Stock - Business Wire